I
Intensity Therapeutics (INTS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Intensity Therapeutics (INTS)
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to treat solid tumor cancers. It leverages its DfuseRx technology platform to create proprietary drug formulations. Its product c... Read more
- USD0.48
- USD0.48
- USD0.43
- USD5.10
- -17.60%
- --
- 1.00
- 1.37M
- 9M
- 0.29
- -90.60%
Stock News
5 hours ago
Broadcom (AVGO) on Track for Fourth Straight Record Close Ahead of Earnings
Yahoo
yesterday
We're lifting our price target on Broadcom after its AI business impresses once again
CNBC
yesterday
Jim Cramer analyzes stocks that recently hit new 52-week highs
CNBC
yesterday
Trump Media seeks bitcoin ETF in latest move into crypto
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
